John E Bisi (John Bisi)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 2

Top Topics

Locally Advanced

Blood Brain Barrier

Top Venues

Science translational medicine

Cancer discovery

G1 Therapeutics, Inc.

This page only lists publications with an associated author ORCID identifier.

Affiliation History

G1 Therapeutics, Inc.

United States

Director :: Preclinical Research and Development

GlaxoSmithKline Plc

United States

Investigator :: Genomics and Proteomic Sciences

Publications

Catherine Dietrich, Alec Trub, Antonio Ahn, Michael Taylor, Krutika Ambani, Keefe T Chan, Kun-Hui Lu, Christabella A Mahendra, Catherine Blyth, Rhiannon Coulson, Susanne Ramm, April C Watt, Sunil Kumar Matsa, John E Bisi, Jay Strum, Patrick Roberts, Shom Goel
INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors. Cancer discovery (2023)
Shenghui He, Patrick J Roberts, Jessica A Sorrentino, John E Bisi, Hannah Storrie-White, Renger G Tiessen, Karenann M Makhuli, William A Wargin, Henko Tadema, Ewoud-Jan van Hoogdalem, Jay C Strum, Rajesh K Malik, Norman E Sharpless
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion. Science translational medicine 9 (387) (2018)